Life Science Investing Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF
Life Science Investing Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025
Life Science Investing Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Finlay Minerals completes Field Work on Newly Identified Geophysical Targets on the SAY and JJB Properties
Aventis Energy Confirms Strong Radioactivity During Successful Exploration Program at the Corvo Uranium Project
Stallion Uranium Appoints Peter Dembicki to Board of Directors, Initiates Haystack Intelligent Targeting Study
